α1β1インテグリンの誘導性リガンドおよび使用

Title:

α1β1インテグリンの誘導性リガンドおよび使用

Document Type and Number:

Japanese Patent JP2006516024

Kind Code:

A

Abstract:

The present invention is directed to the identification and use of agents, particularly peptides and monoclonal antibodies that disrupt the interaction between Collagen XIII and alpha1beta1 integrin.

More Like This:

WO/1998/000527	ISOLATION AND CLONING OF THE HUMAN $i(hARSA-I) GENE AND USES THEREOF
JP2014088386	APROTININ POLYPEPTIDE FOR TRANSPORTING COMPOUND THROUGH BLOOD BRAIN BARRIER
WO/2024/066941	COMPOSITION FOR DETECTING BLADDER CANCER, KIT, AND USE THEREOF

Inventors:

Cosgrove, dominique

Application Number:

JP2004550398A

Publication Date:

June 15, 2006

Filing Date:

October 31, 2003

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Boys Town National Research Hospital

International Classes:

C07K14/47; A61K38/00; A61K38/04; A61K39/395; A61K45/00; A61P1/04; A61P1/16; A61P11/00; A61P13/12; A61P17/06; A61P19/02; A61P29/00; C07K11/00; C07K16/18; C07K16/28; C12Q1/02; G01N33/15; G01N33/50; C12N15/09; A61K; C07K

Attorney, Agent or Firm:

Atsushi Aoki
Takashi Ishida
Fukumoto product
Tetsuji Koga
Tatsunori Ikeda
Masaya Nishiyama

Previous Patent: ノルエピネフリン再取り込み阻害活性及び５−ＨＴ２Ａアンタゴニスト活�...

Next Patent: ビスフェノールＡの精製方法